{"count":4617,"next":"https://www.mitotox.org/api/records/list?format=json&page=46","previous":"https://www.mitotox.org/api/records/list?format=json&page=44","results":[{"rec_id":"RC04835","func":"F01","targ":null,"compound":"D0099: Piroxicam","paper":"40","func_act":"decrease","targ_act":"","dose":"796","time":"24hr","method":"tetramethylrhodamine ethyl ester (TMRE)","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04836","func":"F01","targ":null,"compound":"D0040: Diflunisal","paper":"40","func_act":"decrease","targ_act":"","dose":"115","time":"24hr","method":"tetramethylrhodamine ethyl ester (TMRE)","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04837","func":"F01","targ":null,"compound":"D0010: Acetylsalicylic acid","paper":"40","func_act":"decrease","targ_act":"","dose":"NR","time":"24hr","method":"tetramethylrhodamine ethyl ester (TMRE)","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04838","func":"F01","targ":null,"compound":"D0038: Diclofenac","paper":"40","func_act":"decrease","targ_act":"","dose":"487","time":"24hr","method":"tetramethylrhodamine ethyl ester (TMRE)","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04839","func":"F01","targ":null,"compound":"D0115: Sulindac","paper":"40","func_act":"decrease","targ_act":"","dose":"NR","time":"24hr","method":"tetramethylrhodamine ethyl ester (TMRE)","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04840","func":"F01","targ":null,"compound":"D1451: Sulindac sulfide","paper":"40","func_act":"decrease","targ_act":"","dose":"28","time":"24hr","method":"tetramethylrhodamine ethyl ester (TMRE)","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04841","func":"F01","targ":null,"compound":"D1452: Sulindac sulfone","paper":"40","func_act":"decrease","targ_act":"","dose":"NR","time":"24hr","method":"tetramethylrhodamine ethyl ester (TMRE)","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04842","func":"F01","targ":null,"compound":"D0092: Nimesulide","paper":"40","func_act":"decrease","targ_act":"","dose":"30","time":"24hr","method":"tetramethylrhodamine ethyl ester (TMRE)","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04843","func":"F0504","targ":null,"compound":"D0057: Flufenamic Acid","paper":"40","func_act":"","targ_act":"","dose":"NR","time":"","method":"use CM-H2DCFDA to monitor reactive oxygen species","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04844","func":"F0504","targ":null,"compound":"D0122: Tolfenamic Acid","paper":"40","func_act":"","targ_act":"","dose":"NR","time":"","method":"use CM-H2DCFDA to monitor reactive oxygen species","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04845","func":"F0504","targ":null,"compound":"D0078: Mefenamic acid","paper":"40","func_act":"","targ_act":"","dose":"NR","time":"","method":"use CM-H2DCFDA to monitor reactive oxygen species","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04846","func":"F0504","targ":null,"compound":"D0079: Meloxicam","paper":"40","func_act":"","targ_act":"","dose":"NR","time":"","method":"use CM-H2DCFDA to monitor reactive oxygen species","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04847","func":"F0504","targ":null,"compound":"D1450: Sudoxicam","paper":"40","func_act":"","targ_act":"","dose":"NR","time":"","method":"use CM-H2DCFDA to monitor reactive oxygen species","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04848","func":"F0504","targ":null,"compound":"D0099: Piroxicam","paper":"40","func_act":"","targ_act":"","dose":"NR","time":"","method":"use CM-H2DCFDA to monitor reactive oxygen species","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04849","func":"F0504","targ":null,"compound":"D0040: Diflunisal","paper":"40","func_act":"","targ_act":"","dose":"558","time":"","method":"use CM-H2DCFDA to monitor reactive oxygen species","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04850","func":"F0504","targ":null,"compound":"D0010: Acetylsalicylic acid","paper":"40","func_act":"","targ_act":"","dose":"NR","time":"","method":"use CM-H2DCFDA to monitor reactive oxygen species","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04851","func":"F0504","targ":null,"compound":"D0038: Diclofenac","paper":"40","func_act":"","targ_act":"","dose":"NR","time":"","method":"use CM-H2DCFDA to monitor reactive oxygen species","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04852","func":"F0504","targ":null,"compound":"D0115: Sulindac","paper":"40","func_act":"","targ_act":"","dose":"NR","time":"","method":"use CM-H2DCFDA to monitor reactive oxygen species","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04853","func":"F0504","targ":null,"compound":"D1451: Sulindac sulfide","paper":"40","func_act":"","targ_act":"","dose":"109","time":"","method":"use CM-H2DCFDA to monitor reactive oxygen species","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04854","func":"F0504","targ":null,"compound":"D1452: Sulindac sulfone","paper":"40","func_act":"","targ_act":"","dose":"NR","time":"","method":"use CM-H2DCFDA to monitor reactive oxygen species","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04855","func":"F0504","targ":null,"compound":"D0092: Nimesulide","paper":"40","func_act":"","targ_act":"","dose":"574","time":"","method":"use CM-H2DCFDA to monitor reactive oxygen species","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04856","func":"F0221","targ":null,"compound":"D0057: Flufenamic Acid","paper":"40","func_act":"","targ_act":"","dose":"79","time":"24hr","method":"glutathion depletion: cells were incubated with 50 μM monochlorobimane with 6 μg/ml Hoechst 33342","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04857","func":"F0221","targ":null,"compound":"D0122: Tolfenamic Acid","paper":"40","func_act":"","targ_act":"","dose":"105","time":"24hr","method":"glutathion depletion: cells were incubated with 50 μM monochlorobimane with 6 μg/ml Hoechst 33342","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04858","func":"F0221","targ":null,"compound":"D0078: Mefenamic acid","paper":"40","func_act":"","targ_act":"","dose":"148","time":"24hr","method":"glutathion depletion: cells were incubated with 50 μM monochlorobimane with 6 μg/ml Hoechst 33342","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04859","func":"F0221","targ":null,"compound":"D0079: Meloxicam","paper":"40","func_act":"","targ_act":"","dose":"316","time":"24hr","method":"glutathion depletion: cells were incubated with 50 μM monochlorobimane with 6 μg/ml Hoechst 33342","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04860","func":"F0221","targ":null,"compound":"D1450: Sudoxicam","paper":"40","func_act":"","targ_act":"","dose":"313","time":"24hr","method":"glutathion depletion: cells were incubated with 50 μM monochlorobimane with 6 μg/ml Hoechst 33342","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04861","func":"F0221","targ":null,"compound":"D0099: Piroxicam","paper":"40","func_act":"","targ_act":"","dose":"NR","time":"24hr","method":"glutathion depletion: cells were incubated with 50 μM monochlorobimane with 6 μg/ml Hoechst 33342","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04862","func":"F0221","targ":null,"compound":"D0040: Diflunisal","paper":"40","func_act":"","targ_act":"","dose":"29","time":"24hr","method":"glutathion depletion: cells were incubated with 50 μM monochlorobimane with 6 μg/ml Hoechst 33342","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04863","func":"F0221","targ":null,"compound":"D0010: Acetylsalicylic acid","paper":"40","func_act":"","targ_act":"","dose":"NR","time":"24hr","method":"glutathion depletion: cells were incubated with 50 μM monochlorobimane with 6 μg/ml Hoechst 33342","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04864","func":"F0221","targ":null,"compound":"D0038: Diclofenac","paper":"40","func_act":"","targ_act":"","dose":"167","time":"24hr","method":"glutathion depletion: cells were incubated with 50 μM monochlorobimane with 6 μg/ml Hoechst 33342","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04865","func":"F0221","targ":null,"compound":"D0115: Sulindac","paper":"40","func_act":"","targ_act":"","dose":"896","time":"24hr","method":"glutathion depletion: cells were incubated with 50 μM monochlorobimane with 6 μg/ml Hoechst 33342","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04866","func":"F0221","targ":null,"compound":"D1451: Sulindac sulfide","paper":"40","func_act":"","targ_act":"","dose":"40","time":"24hr","method":"glutathion depletion: cells were incubated with 50 μM monochlorobimane with 6 μg/ml Hoechst 33342","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04867","func":"F0221","targ":null,"compound":"D1452: Sulindac sulfone","paper":"40","func_act":"","targ_act":"","dose":"NR","time":"24hr","method":"glutathion depletion: cells were incubated with 50 μM monochlorobimane with 6 μg/ml Hoechst 33342","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":false},{"rec_id":"RC04868","func":"F0221","targ":null,"compound":"D0092: Nimesulide","paper":"40","func_act":"","targ_act":"","dose":"1","time":"24hr","method":"glutathion depletion: cells were incubated with 50 μM monochlorobimane with 6 μg/ml Hoechst 33342","species":"rat","animal_model":"hepatocytes","criteria":"AC50 (μM)","result":true},{"rec_id":"RC04869","func":"F020403","targ":null,"compound":"D0011: Atenolol","paper":"50","func_act":"","targ_act":"","dose":"300.0 ± 0, 300.0 ± 0, 1, 300.0 ± 0, 300.0 ± 0, 1","time":"4hr","method":"high-glucose–galactose cell viability assay with mitochondrial membrane potential (JC-1) and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )(μM)","result":false},{"rec_id":"RC04870","func":"F020403","targ":null,"compound":"D0844: chloroxine","paper":"50","func_act":"","targ_act":"","dose":"300.0 ± 0, 300.0 ± 0, 1, 300.0 ± 0, 300.0 ± 0, 1","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":false},{"rec_id":"RC04871","func":"F020403","targ":null,"compound":"D0062: Flutamide","paper":"50","func_act":"","targ_act":"","dose":"300.0 ± 0, 183.3 ± 2.9, 1.6, 300.0 ± 0, 205.3 ± 82.4 ,1.6","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":false},{"rec_id":"RC04873","func":"F020403","targ":null,"compound":"D0425: Nilutamide","paper":"50","func_act":"","targ_act":"","dose":"300.0 ± 0, 300.0 ± 0, 1, 300.0 ± 0, 272.5 ± 21.0, 1.1","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":false},{"rec_id":"RC04874","func":"F020403","targ":null,"compound":"D0098: Pioglitazone","paper":"50","func_act":"","targ_act":"","dose":"300.0 ± 0 ,300.0 ± 0, 1, 300.0 ± 0, 300.0 ± 0, 1","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":false},{"rec_id":"RC04875","func":"F020403","targ":null,"compound":"D0108: Rosiglitazone","paper":"50","func_act":"","targ_act":"","dose":"290.3 ± 16.7, 300.0 ± 0, 1, 300.0 ± 0, 300.0 ± 0, 1","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":false},{"rec_id":"RC04876","func":"F020403","targ":null,"compound":"D0124: Troglitazone","paper":"50","func_act":"","targ_act":"","dose":"300.0 ± 0, 300.0 ± 0, 1, 300.0 ± 0, 300.0 ± 0, 1","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":false},{"rec_id":"RC04877","func":"F020403","targ":null,"compound":"D0445: verapamil","paper":"50","func_act":"","targ_act":"","dose":"300.0 ± 0, 300.0 ± 0, 1, 300.0 ± 0, 265.7 ± 59.5, 1.1","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":false},{"rec_id":"RC04878","func":"F020403","targ":null,"compound":"D0464: zimelidine","paper":"50","func_act":"","targ_act":"","dose":"268.7 ± 48.0, 242.3 ± 80.8, 1.1, 257.3 ± 53.7, 249.3 ± 46.4, 1","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":false},{"rec_id":"RC04879","func":"F020403","targ":null,"compound":"D0472: zoniporide","paper":"50","func_act":"","targ_act":"","dose":"300.0 ± 0, 300.0 ± 0, 1, 300.0 ± 0, 251.0 ± 54.7, 1.2","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":false},{"rec_id":"RC04880","func":"F020403","targ":null,"compound":"D0005: Amiodarone","paper":"50","func_act":"","targ_act":"","dose":"75.2 ± 12.9, 92.0 ± 5.5, 0.8, 95.1 ± 10.1 ,69.1 ± 24.1, 1.3","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04881","func":"F020403","targ":null,"compound":"D0006: Amitriptyline","paper":"50","func_act":"","targ_act":"","dose":"70.9 ± 16.8, 72.0 ± 5.3, 1, 68.1 ± 9.1, 67.0 ± 11.6, 1","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04883","func":"F020403","targ":null,"compound":"D0024: Chlorpromazine","paper":"50","func_act":"","targ_act":"","dose":"36.6 ± 19.4, 48.4 ± 11.9, 0.8, 17.3 ± 7.6, 25.3 ± 10.8, 0.7","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04884","func":"F020403","targ":null,"compound":"D0060: Fluoxetine","paper":"50","func_act":"","targ_act":"","dose":"63.4 ± 8.1, 43.1 ± 9.6 ,1.5, 58.0 ± 15.1, 63.3 ± 26.2, 0.9","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04885","func":"F020403","targ":null,"compound":"D0067: Idarubicin","paper":"50","func_act":"","targ_act":"","dose":"7.9 ± 3.3 , 4.2 ± 2.0, 1.9, 11.5 ± 5.7 ,6.2 ± 4.0, 1.9","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04886","func":"F020403","targ":null,"compound":"D0461: imipramine","paper":"50","func_act":"","targ_act":"","dose":"91.6 ± 18.2, 84.1 ± 10.3, 1.1, 71.4 ± 22.4, 90.3 ± 11.7, 0.8","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04888","func":"F020403","targ":null,"compound":"D0448: mefloquine","paper":"50","func_act":"","targ_act":"","dose":"2.9 ± 1.1, 2.3 ± 1.0, 1.4 ,3.4 ± 1.3, 3.6 ± 2.2, 1.2","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04889","func":"F020403","targ":null,"compound":"D0194: Menadione","paper":"50","func_act":"","targ_act":"","dose":"18.0 ± 7.2, 14.7 ± 7.9  ,1.2, 19.5 ± 8.3, 14.0 ± 8.7, 1.4","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04892","func":"F020403","targ":null,"compound":"D1463: Nortriptyline","paper":"50","func_act":"","targ_act":"","dose":"62.0 ± 18.7, 57.8 ± 28.3, 1.1, 65.3 ± 25.0, 49.2 ± 23.0, 1.3","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04893","func":"F020403","targ":null,"compound":"D0441: paroxetine","paper":"50","func_act":"","targ_act":"","dose":"37.5 ± 15.9, 36.9 ± 27.9, 1, 37.1 ± 11.3, 32.3 ± 17.8, 1.2","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04894","func":"F020403","targ":null,"compound":"D0471: sertraline","paper":"50","func_act":"","targ_act":"","dose":"30.7 ± 4.7, 24.7 ± 16.0, 1.2, 29.1 ± 12.0, 23.6 ± 19.2, 1.2","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04895","func":"F020403","targ":null,"compound":"D0116: Tamoxifen","paper":"50","func_act":"","targ_act":"","dose":"97.9 ± 28.0, 64.4 ± 11.4, 1.5, 75.2 ± 8.4, 43.9 ± 7.8, 1.7","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04896","func":"F020403","targ":null,"compound":"D0119: Thioridazine","paper":"50","func_act":"","targ_act":"","dose":"31.0 ± 5.9, 27.7 ± 19.8 ,1.4, 24.4 ± 5.7, 21.9 ± 18.0, 1.6","time":"4hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04897","func":"F020403","targ":null,"compound":"D0062: Flutamide","paper":"50","func_act":"","targ_act":"","dose":"300.0 ± 0, 78.3 ± 24.8, 4.1, 266 ± 58.9 , 62.6 ± 27.3, 5","time":"24hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04898","func":"F020403","targ":null,"compound":"D0425: Nilutamide","paper":"50","func_act":"","targ_act":"","dose":"250 ± 86.6, 44.0 ± 12.0 , 5.7 , 300.0 ± 0, 15.6 ± 9.9 , 19.2","time":"24hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04899","func":"F020403","targ":null,"compound":"D0124: Troglitazone","paper":"50","func_act":"","targ_act":"","dose":"300.00 ± 0 , 1.4 ± 0.1, 219.8, 300.0 ± 0, 1.9 ± 0.1, 156.7","time":"24hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04900","func":"F020403","targ":null,"compound":"D0472: zoniporide","paper":"50","func_act":"","targ_act":"","dose":"300.00 ± 0, 22.1 ± 14.3, 13.6, 300.0 ± 0, 21.6 ± 5.1,  13.9","time":"24hr","method":"high-glucose–galactose cell viability assay with JC-1 mitochondrial membrane potential and ATP-depletion assays (CellTiter-Glo reagent ).","species":"","animal_model":"H9c2 cells","criteria":"glucose/galactose IC50 ratio (JC-1 IC50 in glucose, JC-1 IC50 in galactose, JC-1 glu/gla, ATP IC50 in glucose, ATP IC50 in galactose, ATP glu/gla )","result":true},{"rec_id":"RC04901","func":"F020403","targ":null,"compound":"D0009: Antimycin A","paper":"325","func_act":"","targ_act":"","dose":"5.9 (42.1nM/7.1nM)","time":"24hr","method":"ATP levels in  high-glucose (25 mM) or galactose (10 mM)  medium","species":"","animal_model":"L6","criteria":"glucose/galactose IC50 ratio","result":true},{"rec_id":"RC04902","func":"F020403","targ":null,"compound":"D0009: Antimycin A","paper":"325","func_act":"","targ_act":"","dose":"10.7 (176.5nM/16.5nM)","time":"24hr","method":"ATP levels in  high-glucose (25 mM) or galactose (10 mM)  medium","species":"","animal_model":"H9c2","criteria":"glucose/galactose IC50 ratio","result":true},{"rec_id":"RC04903","func":"F020403","targ":null,"compound":"D0009: Antimycin A","paper":"325","func_act":"","targ_act":"","dose":"17.7(58.1nM/3.3nM)","time":"24hr","method":"ATP levels in  high-glucose (25 mM) or galactose (10 mM)  medium","species":"","animal_model":"HepG2","criteria":"glucose/galactose IC50 ratio","result":true},{"rec_id":"RC04904","func":"F020403","targ":null,"compound":"D1467: 1-Octylguanidine","paper":"326","func_act":"","targ_act":"","dose":"4.3","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04905","func":"F020403","targ":null,"compound":"D0129: 2,4-dinitrophenol","paper":"326","func_act":"","targ_act":"","dose":"2.1","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04906","func":"F020403","targ":null,"compound":"D1378: 3-Bromopyruvate","paper":"326","func_act":"","targ_act":"","dose":"1","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04907","func":"F020403","targ":"T004","compound":"D0132: 3-NPA","paper":"326","func_act":"","targ_act":"inhibit","dose":"","time":"","method":"Assessment of the function of individual mitochondrial complexes  using Agilent Seahorse XFe24","species":"","animal_model":"permeabilized LUHMES cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04908","func":"F020403","targ":null,"compound":"D0309: Albendazole","paper":"326","func_act":"","targ_act":"","dose":"1","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04909","func":"F020403","targ":"T004","compound":"D0009: Antimycin A","paper":"326","func_act":"","targ_act":"","dose":"12000","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04910","func":"F020403","targ":"T002","compound":"D0524: atpenin a5","paper":"326","func_act":"","targ_act":"","dose":"1.2","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04911","func":"F020403","targ":"T004","compound":"D0541: azoxystrobin","paper":"326","func_act":"","targ_act":"","dose":"3.6","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04912","func":"F020403","targ":null,"compound":"D1468: BAM15","paper":"326","func_act":"","targ_act":"","dose":"1.4","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04913","func":"F020403","targ":"T001","compound":"D0251: Berberine","paper":"326","func_act":"","targ_act":"","dose":"7","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04914","func":"F020403","targ":null,"compound":"D1473: Bortezomib","paper":"326","func_act":"","targ_act":"","dose":"0.9","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04915","func":"F020403","targ":null,"compound":"D1401: Brefeldin A","paper":"326","func_act":"","targ_act":"","dose":"0.7","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04916","func":"F020403","targ":null,"compound":"D0325: Capsaicin","paper":"326","func_act":"","targ_act":"","dose":"","time":"","method":"Assessment of the function of individual mitochondrial complexes  using Agilent Seahorse XFe24","species":"","animal_model":"permeabilized LUHMES cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04917","func":"F020403","targ":null,"compound":"D1475: Carbaryl","paper":"326","func_act":"","targ_act":"","dose":"","time":"","method":"Assessment of the function of individual mitochondrial complexes  using Agilent Seahorse XFe24","species":"","animal_model":"permeabilized LUHMES cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04918","func":"F020403","targ":"T002","compound":"D0256: Carboxin","paper":"326","func_act":"","targ_act":"","dose":"3.1","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04919","func":"F020403","targ":null,"compound":"D0156: CCCP","paper":"326","func_act":"","targ_act":"","dose":"1.2","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04920","func":"F020403","targ":null,"compound":"D0029: Cisplatin","paper":"326","func_act":"","targ_act":"","dose":"1","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04921","func":"F020403","targ":null,"compound":"D1372: colchicine","paper":"326","func_act":"","targ_act":"","dose":"0.5","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04922","func":"F0105","targ":null,"compound":"D1476: Cyazofamid","paper":"326","func_act":"","targ_act":"","dose":"50µM ","time":"","method":"Assessment of the function of individual mitochondrial complexes  using Agilent Seahorse XFe24","species":"","animal_model":"permeabilized LUHMES cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04923","func":"F020403","targ":null,"compound":"D1474: Cytochalasin D","paper":"326","func_act":"","targ_act":"","dose":"1.5","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04924","func":"F020403","targ":"T001","compound":"D0221: Deguelin","paper":"326","func_act":"","targ_act":"","dose":"450","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04926","func":"F020403","targ":null,"compound":"D0172: Diethylstilbestrol","paper":"326","func_act":"","targ_act":"","dose":"1","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04927","func":"F020403","targ":null,"compound":"D0043: Doxorubicin","paper":"326","func_act":"","targ_act":"","dose":"0.5","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04928","func":"F020403","targ":null,"compound":"D0181: FCCP","paper":"326","func_act":"","targ_act":"","dose":"2.5","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04929","func":"F020403","targ":null,"compound":"D0924: fenamidone","paper":"326","func_act":"","targ_act":"","dose":"16","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04930","func":"F020403","targ":null,"compound":"D1250: fenazaquin","paper":"326","func_act":"","targ_act":"","dose":"450","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04932","func":"F020403","targ":"T001","compound":"D0145: Fenpyroximate","paper":"326","func_act":"","targ_act":"","dose":"5600","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04933","func":"F020403","targ":null,"compound":"D0523: flutolanil","paper":"326","func_act":"","targ_act":"","dose":"0.9","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04934","func":"F020403","targ":null,"compound":"D0355: Hexachlorophene","paper":"326","func_act":"","targ_act":"","dose":"1.6","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04937","func":"F020403","targ":null,"compound":"D0988: mepronil","paper":"326","func_act":"","targ_act":"","dose":"1.2","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04938","func":"F020403","targ":null,"compound":"D0200: Methylmercury","paper":"326","func_act":"","targ_act":"","dose":"1.1","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04939","func":"F020403","targ":null,"compound":"D1471: Methyltriphenylphosphonium bromide","paper":"326","func_act":"","targ_act":"","dose":"8.6","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04940","func":"F020403","targ":null,"compound":"D1416: MG-132","paper":"326","func_act":"","targ_act":"","dose":"1.4","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04941","func":"F020403","targ":null,"compound":"D1477: Monastrol","paper":"326","func_act":"","targ_act":"","dose":"","time":"","method":"Assessment of the function of individual mitochondrial complexes  using Agilent Seahorse XFe24","species":"","animal_model":"permeabilized LUHMES cells","criteria":" EC25(NA) [Glc/Gal]","result":false},{"rec_id":"RC04942","func":"F020403","targ":"T001","compound":"D0203: MPP","paper":"326","func_act":"","targ_act":"","dose":"30","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":true},{"rec_id":"RC04943","func":"F020403","targ":null,"compound":"D1472: Narciclasine","paper":"326","func_act":"","targ_act":"","dose":"1.5","time":"","method":"Glc–Gal–NeuriTox assay","species":"","animal_model":"LUHMES (Lund human mesencephalic) cells","criteria":" EC25(NA) [Glc/Gal]","result":false}]}